Clinical Trial Update: Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery [NA]

View source ↗

Summary

Completed clinical trial evaluating the Zilver PTX paclitaxel-coated drug-eluting stent in above-the-knee femoropopliteal arteries; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Zilver PTX Drug-Eluting Stent (paclitaxel-coated nitinol drug-eluting stent)

Snippet

Sponsor: Cook Group Incorporated | Conditions: Peripheral Vascular Diseases | NA | Status: COMPLETED | Results posted: 2014-08-11